Clinical utility of plasma percent donor-derived cell-free DNA for lung allograft surveillance: A real-world single-center experience
%dd-cfDNA may have limited utility as a screening tool to detect ACR and/or RI among LTRs.
Authors
- Katherine Grief (ORCID: https://orcid.org/0000-0003-4251-5670)
- D. Sindu (ORCID: https://orcid.org/0000-0002-4420-3622)
- Rajat Walia (ORCID: https://orcid.org/0000-0001-5036-2921)
- R. Curtis Bay (ORCID: https://orcid.org/0000-0003-3525-9269)
- Sofya Tokman (ORCID: https://orcid.org/0000-0003-2821-8776)
Institutions
- Creighton University (US)
- St. Joseph's Hospital and Medical Center (US)
- University of Phoenix (US)
- St. Joseph's Hospital (US)
- A.T. Still University (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1016/j.jhlto.2024.100141
- Citations
- 2
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.15